MPS Management Change
MPS Ltd appointed Mr. Atul Vohra as an Additional Director, effective July 6, 2026, pending shareholder approval. His profile highlights global leadership experience across multiple sectors.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
39 announcements with these filters
MPS Ltd appointed Mr. Atul Vohra as an Additional Director, effective July 6, 2026, pending shareholder approval. His profile highlights global leadership experience across multiple sectors.
Mr. Raman Sapra resigned as Company Secretary and Compliance Officer of MPS Limited, effective August 2026. The departure for personal reasons triggers a management transition.
MPS Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with no new deviations noted.
MPS Limited reports FY26 as its most profitable year, driven by AI-led knowledge solutions and the acquisition of Unbound Medicine.
MPS closed FY26 with record profitability, driven by its transformation into an AI-first knowledge solutions provider and the successful integration of Unbound Medicine.
MPS Limited's board decided not to recommend a final dividend for FY2025-26. Capital is being retained to support growth following the Unbound Medicine acquisition.
MPS Limited reported record FY26 EPS of ₹102.11 (+16.3% YoY) with consolidated EBITDA of ₹236 Cr (30.7% margin), driven by an AI-first strategy and the Unbound Medicine acquisition.
MPS Ltd reported revenue from operations of ₹205.2 Cr (+12.7% YoY) and net profit of ₹47 Cr (-0.2% YoY) for Q4 FY26.
MPS Limited announced the voluntary de-registration of its Australian step-down subsidiary, App-eLearn Pty Ltd. The closure has no material impact on the company's consolidated financials.